|Bid||450.58 x 1000|
|Ask||450.67 x 1100|
|Day's range||447.07 - 453.14|
|52-week range||303.50 - 456.63|
|Beta (5Y monthly)||0.95|
|PE ratio (TTM)||44.33|
|Forward dividend & yield||3.08 (0.69%)|
|Ex-dividend date||24 Nov 2021|
|1y target est||N/A|
S&P Global (SPGI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The young biopharma outfit is set to become part of a major market index, which means a buying spree is on the radar.